Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

President’s Message

Philip Baer • Edition: Winter 2021

Life is a marathon, not a sprint. The same applies to pandemics. As each of you are doing personally and professionally, at the ORA we are soldiering on, one day at a time.

As you know, we were successful in the battle to ensure that E078 premiums can be billed with the K083 code. For those who previously billed for non-OTN virtual visits using only the K083 equivalent of the base visit fees, OHIP instituted a K084 code to allow you to bill the balance, equivalent to the value of E078. Details were provided via an ORA e-blast and are on our website.

We have been advocating through the OMA and the Ministry of Health to ensure that access to the COVID-19 vaccine is prioritized, not only for hospital-based health care workers, but also for community-based physicians and their office staff. Rheumatologists are often community-based, and the work being done there to stabilize our complex patients and keep them out of acute-care settings must be recognized.

Our November Industry Council was held virtually. We updated our industry partners on ORA activities and plans. We held 1:1 breakout meeting with current and potential ORA sponsors, unveiling our revised corporate sponsorship and Annual Scientific Meeting virtual lounge documents, which have been well-received and are fully compliant with IMC and PAAB guidelines for interactions with the pharmaceutical industry. We held a successful Board meeting in January, and an ORA Town Hall with Dr. Zain Chagla on February 4th. In addition to COVID-19 and COVID vaccine topics, the developing issue of pre-authorization companies imposing barriers to advanced therapies and news about SADIE were also covered. All Board and Committee meetings and workshops will remain virtual in the short and medium-term.

The ORA Annual Scientific Meeting (ASM) will be held from May 28-30, 2021, using an innovative and interactive virtual format. Dr. Janet Pope has organized a superb event, assisted by our ORA ASM Committee. Our star-studded roster of speakers includes Drs. Joseph Smolen, Maya Buch, Michelle Petri, Jeffrey Curtis, Christopher Ritchlin, Robert Inman, Shahin Jamal, Robert Bell and Jason Lee. Full details can be found on our website www.ontariorheum.ca . Registration should begin in March, with early-bird pricing available.

All ORA committees continue to actively function and deal with their mandates. The new Northern Ontario committee, chaired by Sahil Koppikar, conducted two virtual workshops in January, both of which were fully subscribed. We have also learned of extreme shortages of rheumatologists in Eastern Ontario, and a similar initiative to remedy the situation there is now underway, led by Dr. Ashley Sterrett.

The Informatics Committee is working on launching phase 1 of the ORDER project, aiming to create a dashboard for a rheumatology EMR, which will allow participants to view their own practice outcomes, and compare themselves to the aggregate of participating rheumatologists within the province. The ultimate goal remains to provide an enhanced EMR user experience, while improving patient outcomes in a measurable fashion. Dr. Tom Appleton has led this effort diligently for years, working with his very engaged committee members. Atlysian Solutions is our project manager, and we are working with multiple vendors aiming to pilot this work later in 2021.

Our ORA Government Affairs Committee (formerly the EAP Committee) has also been busy. We arranged a meeting with Dan McLean, the new head of pCPA, and will continue to engage with them on improving drug access to innovative therapies. Mid-February 2021 is expected to bring the launch of multiple adalimumab biosimilars.  We are educating new companies entering the rheumatology space to ensure that patients are not disadvantaged when transitioning to biosimilars.

Our ORA Board, Executive, Committee chairs and Committee members continue to work diligently on behalf of the ORA membership and their patients during these challenging times. Please consult the ORA website or contact us if we can assist with any practice issues. As well, there are always opportunities for ORA members to participate in ORA activities and committees. Check out our website for more information.

Membership renewal notices for 2021 have been sent. Please renew your ORA membership and complete the renewal questionnaire, which is very helpful to us for ORA planning purposes. Your membership dues are essential in maintaining the ORA on a sound financial footing to support all of our activities.

Stay sane, stay safe!

Other Articles in the Winter 2021 Newsletter

  • Interview With Ashley Sterrett on ArthritisAtHome
  • Informatics Update on the ORDER Project
  • Government Affairs Committee Update
  • Prior Authorization
  • Emerging Rheumatologists of Ontario
  • OMA Section on Rheumatology Report
  • Communications Update
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • Biosimilar Fact Sheet
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • BecomeA Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy